Management of Mesh-Related Pelvic Inflammation
- 27 Downloads
Purpose of Review
To review mesh used for transvaginal surgeries, specifically slings and prolapse repairs, as well as offer a review of management after mesh-induced inflammation occurs.
There have been changes to FDA notifications regarding vaginal mesh, with continued high-profile press. The inflammatory changes and possible complications vary with different mesh characteristics. Risk for complications due to transvaginal mesh placed for prolapse is higher than that when placed for the treatment of stress urinary incontinence.
Transvaginal mesh aids in the effective treatment of female stress incontinence and pelvic organ prolapse but holds the possibility for complications. Placement of transvaginal mesh should continue in the hands of specially trained surgeons, who are knowledgeable regarding management of complications.
KeywordsTransvaginal mesh Inflammation Pelvic organ prolapse Stress urinary incontinence
Compliance With Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 3.Urogynecologic Surgical Mesh: update on the Safety and Effectiveness of Transvaginal Placement for Pelvic Organ Prolapse. www.fda.gov/downloads/medicaldevices/safety/alertsandnotices/ucm262760.pdf.
- 4.Reclassification of Urogynecologic Surgical Mesh Instrumentation Food and Drug Administrtion Executive Summary. www.fda.gov/.../medicaldevicesadvisorycommittee/gastroenterology-urologydevicespanel/ucm487224.pdf.
- 21.• Clemons JL, Weinstein M, Guess MK, Alperin M, Moalli P, Gregory WT, et al. Impact of the 2011 FDA transvaginal mesh safety update on AUGS members’ use of synthetic mesh and biologic grafts in pelvic reconstructive surgery. Female Pelvic Med Reconstr Surg. 2013;19(4):191–8 A study looking at mesh trends after the 2011 FDA transvaginal mesh safety update. CrossRefGoogle Scholar
- 23.Novara G, Artibani W, Barber MD, Chapple CR, Costantini E, Ficarra V, et al. Updated systematic review and meta-analysis of the comparative data on colposuspensions, pubovaginal slings, and midurethral tapes in the surgical treatment of female stress urinary incontinence. Eur Urol. 2010;58(2):218–38.CrossRefGoogle Scholar
- 24.• Glazener CM, Breeman S, Elders A, Hemming C, Cooper KG, Freeman RM, et al. Mesh, graft, or standard repair for women having primary transvaginal anterior or posterior compartment prolapse surgery: two parallel-group, multicentre, randomised, controlled trials (PROSPECT). Lancet. 2017;389(10067):381–92 Prospective study looking at mesh, graft vs native repair for treatment of prolapse. CrossRefGoogle Scholar
- 26.Jonsson Funk M, Edenfield AL, Pate V, Visco AG, Weidner AC, Wu JM. Trends in use of surgical mesh for pelvic organ prolapse. Am J Obstet Gynecol. 2013;208(1):79 e71–7.Google Scholar
- 33.FDA Public Health Notification. Serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence. 2008.Google Scholar